retatrutide and liver Triple hormone receptor agonist for metabolic dysfunction-associated steatotic disease: a randomized phase 2a trial retatrutide nafld significantly improved liver

Its one of five main hormones that regulates appetite , playing a significant role in appetite control, satiety, and gastric emptying

In a phase 2 randomised controlled trial published in the New England Journal of Medicine (Jastreboff et al., 2023), participants receiving the highest doses of retatrutide achieved a mean weight reduction of approximately 1724% of body weight over 48 weeks, depending on dose

Ozempic (semaglutide) has gained widespread recognition for its effectiveness in controlling blood glucose levels in patients affected by type 2 diabetes

Syngal S, Coakley EH, Willett WC, Byers T, Williamson DF, Colditz GA